Literature DB >> 5054588

Relation of propranolol plasma level to beta-blockade during oral therapy.

R Zacest, J Koch-Weser.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5054588     DOI: 10.1159/000136287

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


× No keyword cloud information.
  19 in total

1.  Pharmacokinetics and pharmacodynamics of alprenolol in the treatment of hypertension. I. Relationship between plasma concentration and adrenergic beta-receptor blockade.

Authors:  P Collste; K Haglund; M Frisk-Holmberg; M D Rawlins
Journal:  Eur J Clin Pharmacol       Date:  1976-06-15       Impact factor: 2.953

2.  Clinical pharmacokinetics of beta-adrenoreceptors blockers.

Authors:  G Johnsson; C G Regårdh
Journal:  Drugs       Date:  1976       Impact factor: 9.546

3.  THE USE OF NON-INVASIVE TECHNIQUES IN MANAGEMENT OF PATIENTS WITH ANGINA PECTORIS ON ORAL PROPRANOLOL.

Authors:  William H. Frishman; Charles Smithen; Paul Kligfield; Thomas Killip
Journal:  Cardiovasc Dis       Date:  1974

Review 4.  The assessment of beta-adrenoceptor blocking drugs in man.

Authors:  D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1977-08       Impact factor: 4.335

5.  Pharmacokinetic-pharmacodynamic (PK-PD) modeling of cardiovascular effects of metoprolol in spontaneously hypertensive rats: a microdialysis study.

Authors:  Christian Höcht; Carla Di Verniero; Javier A W Opezzo; Guillermo F Bramuglia; Carlos A Taira
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-05-30       Impact factor: 3.000

6.  Concentration-effect relationships with FM 24: a new long acting beta-adrenergic receptor antagonist.

Authors:  C T Dollery; H J Dargie; J Sassard; G Cuisinaud
Journal:  Br J Clin Pharmacol       Date:  1983-06       Impact factor: 4.335

Review 7.  Clinical relevance of pharmacokinetics.

Authors:  G Tognoni; C Bellantuono; M Bonati; M D'Incalci; M Gerna; R Latini; M Mandelli; M G Porro; E Riva
Journal:  Clin Pharmacokinet       Date:  1980 Mar-Apr       Impact factor: 6.447

8.  Plasma concentrations of propranolol and 4-hydroxypropranolol during chronic oral propranolol therapy.

Authors:  L Wong; R L Nation; W L Chiou; P K Mehta
Journal:  Br J Clin Pharmacol       Date:  1979-08       Impact factor: 4.335

9.  Comparison of once and twice daily administration of sotalol in the treatment of hypertension.

Authors:  I Parvinen; E Paukkala
Journal:  Eur J Clin Pharmacol       Date:  1979-06-12       Impact factor: 2.953

10.  Induction of propranolol metabolism by rifampicin.

Authors:  R J Herman; K Nakamura; G R Wilkinson; A J Wood
Journal:  Br J Clin Pharmacol       Date:  1983-11       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.